Literature DB >> 97424

Therapeutic effect of immunization with OEP, protease toxoid and elastase toxoid on corneal ulcers in mice due to Pseudomonas aeruginosa infection.

Y Hirao, J Y Homma.   

Abstract

The effectiveness of immunizing mice with protease toxoid (PT) or elastase toxoid (ET) on the corneal ulcerization due to either protease or elastase were investigated. Consequently, mice immunized with either PT or ET were protected from corneal ulcers experimentally induced by the homologous enzyme, either protease or elastase. Similarly, two kinds of rabbit immune sera, anti-PT and anti-ET, were found to prevent corneal ulcers by the homologous enzyme. Then, the therapeutic effects of vaccination with a single or mixed vaccine consisting of one, two or three components, i.e., PT, ET and/or the common antigen (OEP) of Pseudomonas aeruginosa, were examined on corneal ulcers in mice produced by live cultures of the bacteria. For the same purpose, administration of a single or combined rabbit immune sera against PT, ET and OEP was conducted. As a result, vaccination with the three-component-mixed vaccine or administration with rabbit immune sera combined with anti-PT and anti-ET sera in addition to anti-OEP serum, were found to be the most effective in preventing corneal ulceration as well as in treating corneal ulcers in mice.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 97424

Source DB:  PubMed          Journal:  Jpn J Exp Med        ISSN: 0021-5031


  9 in total

Review 1.  Recent developments for Pseudomonas vaccines.

Authors:  Anurag Sharma; Anja Krause; Stefan Worgall
Journal:  Hum Vaccin       Date:  2011-10-01

2.  Proteinases produced by pseudomonads isolated from sheep fleece.

Authors:  C J London; I P Griffith; A A Kortt
Journal:  Appl Environ Microbiol       Date:  1984-01       Impact factor: 4.792

3.  Isolation and characterization of alkaline protease-deficient mutants of Pseudomonas aeruginosa in vitro and in a mouse eye model.

Authors:  T R Howe; B H Iglewski
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

4.  Protease and elastase of Pseudomonas aeruginosa: inactivation of human plasma alpha 1-proteinase inhibitor.

Authors:  K Morihara; H Tsuzuki; K Oda
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

5.  Transposon mutagenesis of Pseudomonas aeruginosa exoprotease genes.

Authors:  M J Stapleton; K S Jagger; R L Warren
Journal:  J Bacteriol       Date:  1984-01       Impact factor: 3.490

6.  Protease phenotypes of Pseudomonas aeruginosa isolated from patients with cystic fibrosis.

Authors:  K S Jagger; D R Bahner; R L Warren
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

Review 7.  Animal models of bacterial keratitis.

Authors:  Mary E Marquart
Journal:  J Biomed Biotechnol       Date:  2011-01-04

8.  Detection by enzyme-linked immunosorbent assays of antibody specific for Pseudomonas proteases and exotoxin A in sera from cystic fibrosis patients.

Authors:  K S Jagger; D L Robinson; M N Franz; R L Warren
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 11.677

Review 9.  Potential Therapeutic Targets for Combination Antibody Therapy against Pseudomonas aeruginosa Infections.

Authors:  Luke L Proctor; Whitney L Ward; Conner S Roggy; Alexandra G Koontz; Katie M Clark; Alyssa P Quinn; Meredith Schroeder; Amanda E Brooks; James M Small; Francina D Towne; Benjamin D Brooks
Journal:  Antibiotics (Basel)       Date:  2021-12-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.